Toshihiro Kishikawa

Toshihiro Kishikawa

Auto-generated profile, based on publicly available information

Toshihiro Kishikawa

Department of Statistical Genetics, Graduate School of Medicine, University of Osaka, Suita, Osaka 565-0871, Japan

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2022 in Stroke
Verified
Journal Article
Closed access
PDF file
SKShuhei Kawabata
Shuhei Kawabata
MTMasatoshi Takagaki
Masatoshi Takagaki
HNHajime Nakamura
Hajime Nakamura
HOHiroya Oki
Hiroya Oki
DMDaisuke Motooka
Daisuke Motooka
HKHaruhiko Kishima
Haruhiko Kishima
Background and Purpose: Environmental factors are important with respect to the rupture of cerebral aneurysms. However, the relationship between the gut microbiome, an environmental factor, and aneurysm rupture is unclear. Therefore, we compared the gut microbiome in patients with unruptured intracranial aneurysms (UIAs) and ruptured aneurysms (RAs) to identify the specific bacteria causing the rupture of cerebral aneurysms. Methods: A multicenter, prospective case-control study was conducted over one year from 2019 to 2020. The fecal samples of patients with stable UIAs and RAs immediately after onset were collected. Their gut microbiomes were analyzed using 16S rRNA sequencing. Subsequently, a phylogenetic tree was constructed, and polymerase chain reaction was performed to identify the specific species. Results: A total of 28 RAs and 33 UIAs were included in this study. There was no difference in patient characteristics between RAs and UIAs: age, sex, hypertension, dyslipidemia, diabetes status, body mass index, and smoking. No difference was observed in alpha diversity; however, beta diversity was significantly different in the unweighted UniFrac distances. At the phylum level, the relative abundance of Campylobacter in the RA group was larger than that in the UIA group. Furthermore, the gut microbiome in the RA and UIA groups exhibited significantly different taxonomies. However, Campylobacter was focused on because it is widely known as pathogenic among these bacteria. Then, a phylogenetic tree of operational taxonomic units related to Campylobacter was constructed and 4 species were identified. Polymerase chain reaction for these species identified that the abundance of the genus Campylobacter and Campylobacter ureolyticus was significantly higher in the RA group. Conclusions: The gut microbiome profile of patients with stable UIAs and RAs were significantly different. The genus Campylobacter and Campylobacter ureolyticus may be associated with the rupture of cerebral aneurysms.

24 May 2022 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
YOYuriko Otake-Kasamoto
Yuriko Otake-Kasamoto
HKHisako Kayama
Hisako Kayama
TKToshihiro Kishikawa
Toshihiro Kishikawa
Shinichiro ShinzakiShinichiro Shinzaki
Shinichiro Shinzaki
TTTaku Tashiro
Taku Tashiro
TTTetsuo Takehara
Tetsuo Takehara
Microbiota alteration and IFN-γ–producing CD4+ T cell overactivation are implicated in Crohn’s disease (CD) pathogenesis. However, it remains unclear how dysbiosis enhances Th1 responses, leading to intestinal inflammation. Here, we identified key metabolites derived from dysbiotic microbiota that induce enhanced Th1 responses and exaggerate colitis in mouse models. Patients with CD showed elevated lysophosphatidylserine (LysoPS) concentration in their feces, accompanied by a higher relative abundance of microbiota possessing a gene encoding the phospholipid-hydrolyzing enzyme phospholipase A. LysoPS induced metabolic reprogramming, thereby eliciting aberrant effector responses in both human and mouse IFN-γ–producing CD4+ T cells. Administration of LysoPS into two mouse colitis models promoted large intestinal inflammation. LysoPS-induced aggravation of colitis was impaired in mice lacking P2ry10 and P2ry10b, and their CD4+ T cells were hyporesponsive to LysoPS. Thus, our findings elaborate on the mechanism by which metabolites elevated in patients with CD harboring dysbiotic microbiota promote Th1-mediated intestinal pathology.

26 January 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
NSNoah Sasa
Noah Sasa
TKToshihiro Kishikawa
Toshihiro Kishikawa
MMMasashi Mori
Masashi Mori
RIRie Ito
Rie Ito
YMYumie Mizoro
Yumie Mizoro
HIHidenori Inohara
Hidenori Inohara
Integration of human papillomavirus (HPV) into the host genome drives HPV-positive head and neck squamous cell carcinoma (HPV+ HNSCC). Whole-genome sequencing of 51 tumors revealed intratumor heterogeneity of HPV integration, with 44% of breakpoints subclonal, and a biased distribution of integration breakpoints across the HPV genome. Four HPV physical states were identified, with at least 49% of tumors progressing without integration. HPV integration was associated with APOBEC-induced broad genomic instability and focal genomic instability, including structural variants at integration sites. HPV+ HNSCCs exhibited almost no smoking-induced mutational signatures. Heterozygous loss of ataxia-telangiectasia mutated (ATM) was observed in 67% of tumors, with its downregulation confirmed by single-cell RNA sequencing and immunohistochemistry, suggesting ATM haploinsufficiency contributes to carcinogenesis. PI3K activation was the major oncogenic mutation, with JAK-STAT activation in tumors with clonal integration and NF-kappa B activation in those without. These findings provide valuable insights into HPV integration in HPV+ HNSCC.

23 December 2020 in Head & Neck
Verified
Journal Article
Closed access
PDF file
TKToshihiro Kishikawa
Toshihiro Kishikawa
MSMotoyuki Suzuki
Motoyuki Suzuki
NTNorihiko Takemoto
Norihiko Takemoto
TFTakahito Fukusumi
Takahito Fukusumi
TMTakahiro Michiba
Takahiro Michiba
HIHidenori Inohara
Hidenori Inohara

18 July 2025 in Science Immunology
Verified
Journal Article
Closed access
BLBo Li
Bo Li
TSTaiki Sakaguchi
Taiki Sakaguchi
HTHaruka Tani
Haruka Tani
TITakayoshi Ito
Takayoshi Ito
MMMari Murakami
Mari Murakami
HKHisako Kayama
Hisako Kayama
Ulcerative colitis (UC) develops through a complicated interaction between the host and microbiota. Intestinal fibroblasts are believed to play crucial roles in the pathogenesis of UC, but the influence of the host-microbiota interaction on the pathophysiology of intestinal fibroblasts remains poorly understood. Here, we demonstrate that OTU deubiquitinase 3 (OTUD3) suppresses pathologic activation of fibroblasts exposed to microbial cyclic GMP-AMP (3′3’-cGAMP) in the colon by deubiquitinating stimulator of interferon genes (STING). Mice harboring a UC risk missense variant in the Otud3 gene showed pathological features of UC in the colon after transplantation of a fecal microbiota with the potential to produce excessive cGAMP from patients with UC. Collectively, these results highlight a mechanism of the interaction between OTUD3 in host fibroblasts and STING-activating microbiota in UC development.

26 August 2023 in Auris Nasus Larynx
Verified
Journal Article
Closed access
TKTakumi Kumai
Takumi Kumai
HSHirotaka Shinomiya
Hirotaka Shinomiya
HSHirofumi Shibata
Hirofumi Shibata
HTHideaki Takahashi
Hideaki Takahashi
TKToshihiro Kishikawa
Toshihiro Kishikawa
MSMasafumi Sakashita
Masafumi Sakashita